CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Net Income Growth by Quarter and Year

Mateon Therapeutics Inc's Net Income results by quarter and year




OXGN Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -0.64 -3.88 -3.33
III Quarter September -0.99 -0.79 -3.96 -3.97
II Quarter June -1.19 -2.43 -3.10 -3.59
I Quarter March -0.68 -3.54 -3.64 -3.32
FY   -2.86 -7.40 -14.58 -14.21



OXGN Net Income third quarter 2019 Y/Y Growth Comment
Mateon Therapeutics Inc in the third quarter recorded net loss of $ -0.99 millions.

According to the results reported in the third quarter, Mateon Therapeutics Inc achieved the best Net Income growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Net Income no change of % ranks overall at the positon no. in the third quarter.




OXGN Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's third quarter 2019 Net Income $ -0.99 millions OXGN's Income Statement
Mateon Therapeutics Inc's third quarter 2018 Net Income $ -0.79 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Net Income Growth >>


OXGN Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Mateon Therapeutics Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's III. Quarter Q/Q Net Income Comment
Despite the fact, that Mateon Therapeutics Inc in the III. Quarter 2019 showed net loss of $ -0.99 millions, some analyst mentioned, that this are slight up side in contrast to the -1.19 millions in the second quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Net Income growth. While Mateon Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's III. Quarter Q/Q Net Income Comment
Despite the fact, that Mateon Therapeutics Inc in the III. Quarter 2019 admitted net loss of $ -0.99 millions, it should be point out, that current results show improvement in contrast to the -1.19 millions in the second quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Net Income growth. While Mateon Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Mateon Therapeutics Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Net Income 12 Months Ending $ -3.50 $ -3.30 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Mateon Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Mateon Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
OXGN's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for OXGN's Competitors
Net Income Growth for Mateon Therapeutics Inc's Suppliers
Net Income Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2019
Alexion Pharmaceuticals, Inc.  41.31 %$ 41.312 millions
Lhc Group, Inc  38.51 %$ 38.509 millions
Addus Homecare Corp  37.25 %$ 37.253 millions
Ensign Group, Inc  36.75 %$ 36.747 millions
Intuitive Surgical, Inc.  36.63 %$ 36.635 millions
Hanger, Inc.  30.26 %$ 30.259 millions
Msa Safety Inc  25.09 %$ 25.095 millions
Illumina, Inc.  24.47 %$ 24.468 millions
Biospecifics Technologies Corp  24.39 %$ 24.388 millions
United Therapeutics Corporation  24.32 %$ 24.319 millions
Medpace Holdings, inc.  24.20 %$ 24.201 millions
Edwards Lifesciences Corporation  21.60 %$ 21.602 millions
Anika Therapeutics, Inc.  21.07 %$ 21.069 millions
Lemaitre Vascular Inc  20.17 %$ 20.167 millions
China Health Industries Holdings, Inc.  19.67 %$ 19.671 millions
Conmed Corporation  19.66 %$ 19.657 millions
Idexx Laboratories Inc  16.76 %$ 16.761 millions
National Research Corporation  16.12 %$ 16.118 millions
Resmed Inc.  13.63 %$ 13.629 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SIEB's Profile

Stock Price

SIEB's Financials

Business Description

Fundamentals

Charts & Quotes

SIEB's News

Suppliers

SIEB's Competitors

Customers & Markets

Economic Indicators

SIEB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071